Comparative performance of current definitions of sarcopenia against the prospective incidence of falls among community-dwelling seniors age 65 and older

Osteoporosis International

Volumn 26, Issue 12, 2015, Pages 2793-2802

  Bischoff Ferrari, H A ^a,b   Orav, J E ^c   Kanis, J A ^d   Rizzoli, R ^e   Schlogl M ^a,b   Staehelin, H B ^f   Willett, W C ^c   Dawson Hughes, B ^g  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF SHEFFIELD   (United Kingdom)

^e GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^f UNIVERSITY OF BASEL   (Switzerland)

^g TUFTS UNIVERSITY   (United States)

Author keywords

Community dwelling seniors; Comparative performance; Falls; Prevalence; Sarcopenia

Indexed keywords

CALCIUM; COLECALCIFEROL; PLACEBO; VITAMIN D;

AGED; ARTICLE; CONTROLLED STUDY; FALLING; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; INCIDENCE; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; MUSCLE MASS; MUSCLE WEAKNESS; PREVALENCE; PRIORITY JOURNAL; SARCOPENIA; ANTHROPOMETRY; COMBINATION DRUG THERAPY; COMPARATIVE STUDY; DEMOGRAPHY; DOUBLE BLIND PROCEDURE; GAIT; HAND STRENGTH; MALE; PATHOPHYSIOLOGY; PHOTON ABSORPTIOMETRY; PHYSIOLOGY; PREVENTION AND CONTROL; PROCEDURES; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; STATISTICS AND NUMERICAL DATA;

ABSORPTIOMETRY, PHOTON; ACCIDENTAL FALLS; AGED; ANTHROPOMETRY; CALCIUM; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; GAIT; HAND STRENGTH; HUMANS; INCIDENCE; MALE; PREVALENCE; PROSPECTIVE STUDIES; RESIDENCE CHARACTERISTICS; SARCOPENIA; SEX FACTORS; VITAMIN D;

EID: 84948711361     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-015-3194-y     Document Type: Article

References (49)

1. Eberstadt N, Groth H. Europe’s coming demographic challenge: unlocking the value of health. American Enterprise Institute for Health Policy Research. 2007
2. Book S. Alliance for aging research. http://www.agingresearch.org. 2013
3. Commission E. Healthy ageing: a keystone of a sustainable Europe. http://ec.europa.eu/health/ph_information/indicators/docs/healthy_ageing_en.pdf. 2007
4. Visser M, Schaap LA (2011) Consequences of sarcopenia. Clin Geriatr Med 27(3):387–399
5. Janssen I, Shepard DS, Katzmarzyk PT, Roubenoff R (2004) The healthcare costs of sarcopenia in the United States. J Am Geriatr Soc 52(1):80–85
6. WHO. A glossary of terms for community health care and services. http://www.who.int/kobe_centre/ageing/ahp_vol5_glossary.pdf. 2004
7. CDC. The state of aging and health in America 2013. http://www.who.int/kobe_centre/ageing/ahp_vol5_glossary.pdf. 2013
8. Commission E. Healthy ageing: a key stone for a sustainable Europe. http://ec.europa.eu/health/archive/ph_information/indicators/docs/healthy_ageing_en.pdf. 2007
9. Motion Ai. Aging in motion: the facts about sarcopenia. http://www.aginginmotion.org/wpcontent/uploads/2011/04/sarcopenia_fact_sheet.pdf. 2013
10. Sayer AA (2010) Sarcopenia. BMJ 341:c4097
11. Evans WJ. Endpoints and indicators for the older population. http://www.ema.europa.eu/docs/en_GB/document_library/Presentation/2012/04/WC500125114.pdf. 2012
12. Fried LP, Tangen CM, Walston J et al (2001) Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 56(3):M146–M156
13. van Kan Abellan G, Andre E, Bischoff Ferrari HA (2009) Carla task force on sarcopenia: propositions for clinical trials. J Nutr Health Aging 13(8):700–707
14. Visser M (2009) Towards a definition of sarcopenia—results from epidemiologic studies. J Nutr Health Aging 13(8):713–716
15. Cruz-Jentoft AJ, Baeyens JP, Bauer JM et al (2010) Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing 39(4):412–423
16. Fielding RA, Vellas B, Evans WJ et al (2011) Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc 12(4):249–256
17. Morley JE, Abbatecola AM, Argiles JM et al (2011) Sarcopenia with limited mobility: an international consensus. J Am Med Dir Assoc 12(6):403–409
18. Vellas B, Pahor M, Manini T et al (2013) Designing pharmaceutical trials for sarcopenia in frail older adults: EU/US task force recommendations. J Nutr Health Aging 17(7):612–618
19. Studenski S (2009) What are the outcomes of treatment among patients with sarcopenia? J Nutr Health Aging 13(8):733–736
20. Morley JE, Baumgartner RN, Roubenoff R, Mayer J, Nair KS (2001) Sarcopenia. J Lab Clin Med 137(4):231–243
21. Baumgartner RN, Koehler KM, Gallagher D et al (1998) Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 147(8):755–763
22. Delmonico MJ, Harris TB, Lee JS et al (2007) Alternative definitions of sarcopenia, lower extremity performance, and functional impairment with aging in older men and women. J Am Geriatr Soc 55(5):769–774
23. Delmonico MJ, Harris TB, Visser M et al (2009) Longitudinal study of muscle strength, quality, and adipose tissue infiltration. Am J Clin Nutr 90(6):1579–1585
24. Rosenberg IH (1997) Sarcopenia: origins and clinical relevance. J Nutr 127(5 Suppl):990S–991S
25. von Haehling S, Morley JE, Anker SD (2010) An overview of sarcopenia: facts and numbers on prevalence and clinical impact. J Cachex Sarcopenia Muscle 1(2):129–133
26. Lang T, Streeper T, Cawthon P, Baldwin K, Taaffe DR, Harris TB (2010) Sarcopenia: etiology, clinical consequences, intervention, and assessment. Osteoporos Int 21(4):543–559
27. Muscaritoli M, Anker SD, Argiles J et al (2010) Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) “cachexia-anorexia in chronic wasting diseases” and “nutrition in geriatrics”. Clin Nutr 29(2):154–159
28. Stevens JA, Corso PS, Finkelstein EA, Miller TR (2006) The costs of fatal and nonfatal falls among older adults. Injur Prevent 12:290–295, 2006
29. Tromp AM, Pluijm SM, Smit JH, Deeg DJ, Bouter LM, Lips P (2001) Fall-risk screening test: a prospective study on predictors for falls in community-dwelling elderly. J Clin Epidemiol 54(8):837–844
30. Tinetti ME, Williams CS (1997) Falls, injuries due to falls, and the risk of admission to a nursing home. N Engl J Med 337(18):1279–1284
31. Sterling DA, O’Connor JA, Bonadies J (2001) Geriatric falls: injury severity is high and disproportionate to mechanism. J Trauma 50(1):116–119
32. Englander F, Hodson TJ, Terregrossa RA (1996) Economic dimensions of slip and fall injuries. J Forensic Sci 41(5):733–746
33. Dawson-Hughes B, Harris SS, Krall EA, Dallal GE (1997) Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med 337(10):670–676
34. Bischoff-Ferrari HA, Orav EJ, Dawson-Hughes B (2006) Effect of cholecalciferol plus calcium on falling in ambulatory older men and women: a 3-year randomized controlled trial. Arch Intern Med 166(4):424–430
35. Buchner DM, Hornbrook MC, Kutner NG et al (1993) Development of the common data base for the FICSIT trials. J Am Geriatr Soc 41(3):297–308
36. Preece MA, O’Riordan JL, Lawson DE, Kodicek E (1974) A competitive protein-binding assay for 25-hydroxycholecalciferol and 25-hydroxyergocalciferol in serum. Clin Chim Acta 54(2):235–242
37. Gallagher D, Visser M, De Meersman RE et al (1997) Appendicular skeletal muscle mass: effects of age, gender, and ethnicity. J Appl Physiol 83(1):229–239
38. Pichard C, Kyle UG, Bracco D, Slosman DO, Morabia A, Schutz Y (2000) Reference values of fat-free and fat masses by bioelectrical impedance analysis in 3393 healthy subjects. Nutrition (Burbank, Los Angeles County, Calif) 16(4):245–254
39. Kelly TL, Wilson KE, Heymsfield SB (2009) Dual energy X-ray absorptiometry body composition reference values from NHANES. PLoS One 4(9):e7038
40. Janssen I, Heymsfield SB, Ross R (2002) Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc 50(5):889–896
41. Studenski SA, Peters KW, Alley DE et al (2014) The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol Sci Med Sci 69(5):547–558
42. Visser M, Deeg DJ, Lips P, Harris TB, Bouter LM (2000) Skeletal muscle mass and muscle strength in relation to lower-extremity performance in older men and women. J Am Geriatr Soc 48(4):381–386
43. Scott D, Hayes A, Sanders KM, Aitken D, Ebeling PR, Jones G (2014) Operational definitions of sarcopenia and their associations with 5-year changes in falls risk in community-dwelling middle-aged and older adults. Osteoporos Int 25(1):187–193
44. Murphy RA, Ip EH, Zhang Q et al (2014) Transition to sarcopenia and determinants of transitions in older adults: a population-based study. J Gerontol A Biol Sci Med Sci 69(6):751–758
45. Kanis JA (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Stud Group Osteop Int 4(6):368–381
46. Correa-de-Araujo R, Hadley E (2014) Skeletal muscle function deficit: a new terminology to embrace the evolving concepts of sarcopenia and age-related muscle dysfunction. J Gerontol A Biol Sci Med Sci 69(5):591–594
47. Cummings SR, Nevitt MC, Kidd S (1988) Forgetting falls. The limited accuracy of recall of falls in the elderly. J Am Geriatr Soc 36(7):613–616
48. Bischoff-Ferrari HA (2011) The role of falls in fracture prediction. Curr Osteoporos Rep 9(3):116–121
49. Newman AB, Kupelian V, Visser M et al (2003) Sarcopenia: alternative definitions and associations with lower extremity function. J Am Geriatr Soc 51(11):1602–1609